Licofelone - Novel Analgesic and Anti-Inflammatory Agent for Osteoarthritis

 
Key Data:
Drug (brand / generic)
Licofelone (ML3000)
Company / licensee
Merckle GmbH and EuroAlliance partners Alfa Wassermann and Lacer
Therapy class
Dual COX/LOX inhibitor
Product description
Inhibits the action of COX and 5-LOX enzymes
Current indication
Treatment of pain and inflammation associated with OA
Market sector
CNS - pain
Development status
Phase III



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development